# Biotricity

- Location (FDA's records): Redwood City, CA
- FDA decisions: 5 (2016–2022): 5 510(k) clearances
- Names in FDA's records: Biotricity (3); Biotricity, Inc. (2)
- Product codes: MWJ (2), DSH (2), DXH (1)
- 510(k) review time since 2016: median 128 days, against 244 for FDA's reviews in the same codes and years (4 of 4 faster)
- Predicates its devices cite: 5 (2 its own); citations of its devices by later devices: 4 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cardiocomm Solutions, Inc.: 1 (https://510kreport.com/company/cardiocomm-solutions)
- RhythMedix, LLC: 1 (https://510kreport.com/company/rhythmedix)
- Braemar Manufacturing, LLC: 1 (https://510kreport.com/company/braemar-manufacturing)

## Firms that cite its devices most
- Kestra Medical Technologies, Inc.: 2 (https://510kreport.com/company/kestra-medical-technologies)

## Its most-cited devices
- K211709: Biotres (2022), cited by 2
- K162571: Bioflux Software (2016), cited by 1
- K172311: BioFlux Device (2017), cited by 1

## Recent decisions
- K222017: Biotres (Jul 28, 2022)
- K211709: Biotres (Jan 19, 2022)
- K201040: Bioflux Software II (Jul 29, 2020)
- K172311: BioFlux Device (Dec 15, 2017)
- K162571: Bioflux Software (Oct 13, 2016)

Source page: https://510kreport.com/company/biotricity